Letko, Brosseau & Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.7M | Sell |
1,112,085
-105
| -0% | -$7.24K | 1.47% | 26 |
|
|
2025
Q1 | $75.4M | Sell |
1,112,190
-2,470
| -0.2% | -$167K | 1.6% | 23 |
|
|
2024
Q4 | $50M | Buy |
1,114,660
+27,180
| +2% | +$1.22M | 0.97% | 43 |
|
|
2024
Q3 | $68.4M | Buy |
1,087,480
+50,215
| +5% | +$3.16M | 1.24% | 33 |
|
|
2024
Q2 | $61.3M | Buy |
1,037,265
+278,110
| +37% | +$16.4M | 1.16% | 39 |
|
|
2024
Q1 | $60.6M | Sell |
759,155
-1,685
| -0.2% | -$134K | 1.05% | 37 |
|
|
2023
Q4 | $60.1M | Sell |
760,840
-10,270
| -1% | -$811K | 1.09% | 34 |
|
|
2023
Q3 | $53.8M | Buy |
771,110
+254,900
| +49% | +$17.8M | 1.05% | 37 |
|
|
2023
Q2 | $35.7M | Buy |
516,210
+10,925
| +2% | +$755K | 0.66% | 55 |
|
|
2023
Q1 | $37.5M | Buy |
505,285
+110,035
| +28% | +$8.18M | 0.7% | 52 |
|
|
2022
Q4 | $36.8M | Sell |
395,250
-880
| -0.2% | -$82K | 0.66% | 58 |
|
|
2022
Q3 | $37.8M | Sell |
396,130
-9,500
| -2% | -$906K | 0.75% | 50 |
|
|
2022
Q2 | $37.6M | Sell |
405,630
-5,690
| -1% | -$527K | 0.67% | 52 |
|
|
2022
Q1 | $41.6M | Sell |
411,320
-12,655
| -3% | -$1.28M | 0.62% | 55 |
|
|
2021
Q4 | $43.7M | Sell |
423,975
-13,500
| -3% | -$1.39M | 0.63% | 53 |
|
|
2021
Q3 | $37.1M | Sell |
437,475
-27,275
| -6% | -$2.31M | 0.54% | 54 |
|
|
2021
Q2 | $38.8M | Sell |
464,750
-7,600
| -2% | -$634K | 0.52% | 59 |
|
|
2021
Q1 | $35.5M | Sell |
472,350
-20,500
| -4% | -$1.54M | 0.48% | 58 |
|
|
2020
Q4 | $33.7M | Buy |
+492,850
| New | +$33.7M | 0.46% | 60 |
|